Tixagevimab,Cilgavimab
AstraZeneca
['great work', 'imab ']
our first year #rheumfellow , presenting "breakthrough acute covid-19 infection during the us omicron surge following administration of tixagevimab/cilgavimab in immunocompromised patients with rheumatologic disorders ! great work!! #acr22 #rheumatology 
Rheumatology Division at Washington University in St. Louis. @WUDeptMedicine @WUSTL